|
|
||||||||
Radiology, Vol 189, 151-152, Copyright © 1993 by Radiological Society of North America
ARTICLES |
FG Shellock, HP Hahn, JH Mink and E Itskovich
Moderate and severe anaphylactoid reactions--while extremely rare--have been reported in association with intravenous administration of gadopentetate dimeglumine. There has been no similar experience related to use of the newly released magnetic resonance (MR) imaging contrast agent gadoteridol. The authors describe a case of vasovagal response and anaphylactoid reaction during intravenous administration of gadoteridol. MR users should be aware of the potential for adverse effects to occur in association with use of gadoteridol and be prepared by implementing appropriate observation procedures for patients receiving this as well as other MR contrast agents. In addition, physiologic monitoring devices and resuscitation equipment should be readily available in the clinical MR setting for proper treatment of patients who may experience moderate to severe adverse reactions.
This article has been cited by other articles:
![]() |
J. R. Dillman, J. H. Ellis, R. H. Cohan, P. J. Strouse, and S. C. Jan Allergic-Like Breakthrough Reactions to Gadolinium Contrast Agents After Corticosteroid and Antihistamine Premedication Am. J. Roentgenol., January 1, 2008; 190(1): 187 - 190. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. R. Dillman, J. H. Ellis, R. H. Cohan, P. J. Strouse, and S. C. Jan Frequency and Severity of Acute Allergic-Like Reactions to Gadolinium-Containing IV Contrast Media in Children and Adults Am. J. Roentgenol., December 1, 2007; 189(6): 1533 - 1538. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. J. Kransdorf and M. D. Murphey Radiologic Evaluation of Soft-Tissue Masses: A Current Perspective Am. J. Roentgenol., September 1, 2000; 175(3): 575 - 587. [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| RADIOLOGY | RADIOGRAPHICS | RSNA JOURNALS ONLINE |